Skip to main content

Table 1 Baseline characteristics and ACT scores

From: A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients

  Recruited Completed
  Group A Group B p Group A Group B p-value
Number of patients 600 663   400 416  
Female %** 58.80 55.70 0.26 59.80 57.90 0.60
Age range n (%)
 18 to 30** 55 (9.17) 68 (10.26) 0.96 32 (8.00) 43 (10.34) 0.69
 31 to 40** 81 (13.50) 89 (13.42) 0.96 58 (14.50) 62 (14.90) 0.69
 41 to 50** 117 (19.50) 122 (18.40) 0.96 79 (19.75) 77 (18.51) 0.69
 51 to 60** 114 (19.00) 125 (18.85) 0.96 73 (18.25) 80 (19.23) 0.69
 61 to 70** 125 (20.83) 136 (20.51) 0.96 82 (20.50) 77 (18.51) 0.69
 71 to 80** 83 (13.83) 88 (13.27) 0.96 59 (14.75) 52 (12.50) 0.69
 Over 81** 25 (4.17) 35 (5.28) 0.96 17 (4.25) 25 (6.01) 0.69
ACT scores
 Median (IQR)* 19 (14.25–23) 17 (17–21) <0.01 19 (15–23) 18 (18–24) <0.01
 5–14 not controlled n(%)** 150 (25.00) 203 (30.60) <0.01 91 (22.80) 121 (29.10) 0.01
 15–19 partially controlled n(%)** 177 (29.50) 223 (33.60) <0.01 114 (28.50) 132 (31.60) 0.01
 20–25 controlled n(%)** 273 (45.50) 237 (35.71) <0.01 195 (48.70) 163 (39.30) 0.01
  1. * Mann-Whitney U test, Median (IQR), p < 0.05
  2. **Chi-square test, p < 0.05